51
Participants
Start Date
April 30, 2012
Primary Completion Date
August 31, 2018
Study Completion Date
August 31, 2018
Gemcitabine and Cisplatin (DD GC)
Patients will receive six cycles of GC administered every 14 days. Gemcitabine 2,500 mg/m2 will be administered intravenously on day 1 and cisplatin 35 mg/m2 will be administered intravenously on days 1 and 2 of a 14 days cycle (with Peg GCSF). A total of six cycles of therapy will be administered followed by radical cystectomy with bilateral pelvic lymph node dissection (PLND)
New York University, New York
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering West Harrison, Harrison
Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack
University of North Carolina, Chapel Hill
Memorial Sloan Kettering at Basking Ridge, Basking Ridge
Memoral Sloan Kettering Cancer Center@Phelps, Sleepy Hollow
University of North Carolina, Chapel Hill
OTHER
New York University
OTHER
Memorial Sloan Kettering Cancer Center
OTHER